Bortezomib, Melphalan, and Prednisone with or Without Daratumumab in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (Alcyone): Final Analysis of an Open-Label, Randomised, Multicentre, Phase 3 Trial

AuthID
 P-018-K2D
25
Author(s)
Mateos, MV
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
Lucio, P
·
[+1]·
[+2]·
[+1]·
[+1]·
Ngo, M
·
Katz, EG
·
Bolyard, K
·
Carson, R
·
Borgsten, F
·
View all authors
Document Type
Article
Year published
2025
Published
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 26, Issue: 5, Pages: 596-608 (13)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 40220771
Scopus: 2-s2.0-105002287608
Wos: WOS:001495892100001
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Mateos, MV;   2 San-Miguel, J;   3 Cavo, M;
4 Suzuki, K;   5 Jakubowiak, A;   6 Knop, S;
7 Doyen, C;   8 Lucio, P;   9 Nagy, Z;
10 Pour, L;   11 Grosicki, S;   12 Crepaldi, A;
13 Liberati, AM;   14 Campbell, P;   15 Yoon, SS;
16 Iosava, G;   17 Fujisaki, T;   18 Garg, M;
19 Ngo, M;   20 Katz, EG;   21 Krevvata, M;
22 Bolyard, K;   23 Carson, R;   24 Borgsten, F;
25 Dimopoulos, M;    

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service